Neurodevelopmental Effects of Propranolol Treatment During Infancy in Infantile Hemangioma Patients.

Introduction And Aim: Propranolol is an effective treatment option for infantile hemangiomas, but there is still insufficient information about neurodevelopmental side effects of propranolol. In our study, the neurodevelopmental levels of infantile hemangioma patients receiving propranolol treatment were examined using the Bayley-III test.

Method: In our single-center, cross-sectional study, patients were recruited between 1 January 2020 and 31 December 2023.

Examination of Elder Abuse and Death Anxiety in Older Adults With a Chronic Disease.

Aim: This study was conducted to examine elder abuse and death anxiety in older adults who had chronic diseases.

Design: The present study is a cross-sectional and correlational study.

Methods: This study was conducted with 200 patients who met the research criteria and agreed to participate in the study and who were admitted to the internal medicine outpatient clinics of a university hospital in Elazig, eastern Turkey.

Risk factors for neurologic sequelae in children and adolescents with hemophilia after intracranial hemorrhage.

Background: Intracranial hemorrhage (ICH) is reportedly rare but has high morbidity and mortality risk in persons with hemophilia. Although the risk factors that facilitate bleeding are known, the factors affecting the sequelae are not well known.

Objectives: We planned to investigate the risk factors for neurologic sequelae in children and adolescents with hemophilia suffering from ICH.

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options.

Background: Hemophilia B (HB), an X-linked recessive inherited bleeding disorder, exhibits a high prevalence among males.

Objectives: To present the first national cohort of persons with HB to define the demographics, clinical characteristics, and treatment patterns in Turkey.

Methods: This multicenter, retrospective study included 433 alive persons with HB registered in 35 centers between 1961 and 2018.

Adaptation of the Shirom-Melamed Burnout Measure in Parents of Turkish Pediatric Oncology Patients.

Objectives: This study was conducted to adapt the Shirom-Melamed Burnout Measure (SMBM) in parents of Turkish pediatric oncology patients.

Methods: This methodological and descriptive study was conducted with 184 parents of pediatric oncology patients from December 2023 to July 2024. Data was collected face to face interviews via an information form and the SMBM.